🔎 Trials Near Me

Akèy › Limfom selil mantèl › Missouri › St. Louis

Etid klinik pou Limfom selil mantèl nan St. Louis, MO

8 etid pou Limfom selil mantèl ap chèche patisipan nan sit nan ak bò kote St. Louis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

Ap rekriteFaz 3
  • Washington University School of Medicine, St Louis
  • Mercy Hospital South, St Louis
  • Siteman Cancer Center-South County, St Louis
  • ak 4 plis
Laj 60 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05976763

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Ap rekriteFaz 3
  • Washington University School of Medicine, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06742996

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Ap rekriteFaz 1/2
  • Washington University School of Medicine, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06697184

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Ap rekriteFaz 1
  • Washington University School of Medicine, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT07121946

DALY II USA/ MB-CART2019.1 for DLBCL

Ap rekriteFaz 2
  • Washington University, St. Louis, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT04792489

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Ap rekriteFaz 1/2
  • Washington University, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Nov 14, 2025 · NCT05643742

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, St Louis
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Limfom selil mantèl nan lòt vil

Lòt etid nan St. Louis

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.